Know what you really own

Unwrap both →

Fund comparison · from official SEC filings

CANC vs LABU: how much do they overlap?

Tema Oncology ETF and Direxion Daily S&P Biotech Bull 3X Shares

Fund A

vs

Fund B

Holdings overlap

19%

of assets, by weight

Shared positions

33

of 57 / 154 holdings

CANC expense ratio

0.75%

net, per year

LABU expense ratio

0.93%

net, per year

Shared holdings

Company

CANC

LABU

R

RVMDREVOLUTION MEDICINES INC

7.72%

1.27%

C

COGTCOGENT BIOSCIENCES INC

4.09%

0.87%

I

IMNMIMMUNOME INC

3.91%

0.70%

C

CELCCELCUITY INC

3.58%

0.92%

?

—Nuvalent Inc

3.37%

0.88%

A

ABBVABBVIE INC

2.80%

0.82%

E

EXELEXELIXIS INC

2.77%

0.94%

B

BBIOBRIDGEBIO PHARMA INC

2.75%

0.88%

C

CGONCG ONCOLOGY INC

2.43%

0.89%

I

IDYAIDEAYA BIOSCIENCES INC

2.27%

0.49%

A

AMGNAMGEN INC

2.11%

0.81%

R

RLAYRELAY THERAPEUTICS INC

1.28%

0.38%

H

HALOHALOZYME THERAPEUTICS INC

1.23%

0.84%

S

SMMTSUMMIT THERAPEUTICS INC

1.20%

1.09%

R

RCUSARCUS BIOSCIENCES INC

1.20%

0.57%

G

GILDGILEAD SCIENCES INC

1.12%

0.79%

E

ERASERASCA INC

1.08%

0.52%

A

ANABANAPTYSBIO INC

0.99%

0.35%

N

NTRANATERA INC

0.54%

0.92%

R

REGNREGENERON PHARMACEUTICALS

0.75%

0.80%

S

SNDXSYNDAX PHARMACEUTICALS INC

0.80%

0.52%

C

CRVSCORVUS PHARMACEUTICALS INC

0.76%

0.33%

A

AVBPARRIVENT BIOPHARMA INC

0.73%

0.23%

I

IOVAIOVANCE BIOTHERAPEUTICS INC

0.65%

0.28%

I

INBXINHIBRX BIOSCIENCES INC

0.60%

0.40%

Only in CANC

L

LLYELI LILLY & CO

4.82%

R

RHHBYROCHE HOLDINGS LTD-SPONS ADR

4.21%

N

NVSEFNOVARTIS AG-REG

4.03%

M

MRKMERCK & CO. INC.

3.57%

A

AZNASTRAZENECA PLC

3.53%

B

BMYBRISTOL-MYERS SQUIBB CO

3.30%

L

LEGNLEGEND BIOTECH CORP-ADR

2.99%

J

JNJJOHNSON & JOHNSON

2.54%

G

GMABGENMAB A/S -SP ADR

2.37%

Z

ZLABZAI LAB LTD-ADR

1.98%

O

ONCBEONE MEDICINES LTD-ADR

1.88%

Z

ZYMEZYMEWORKS INC

1.51%

E

ELVNENLIVEN THERAPEUTICS INC

1.31%

I

IMTXIMMATICS NV

1.12%

F

FXFXXFIRST AM TREAS OBLI-X

1.09%

N

NUVBNUVATION BIO INC

1.07%

U

URGNUROGEN PHARMA LTD

0.93%

G

GHGUARDANT HEALTH INC

0.81%

C

CHGCFCHUGAI PHARMACEUTICAL CO LTD

0.67%

I

IMCRIMMUNOCORE HOLDINGS PLC-ADR

0.51%

B

BBOTBRIDGEBIO ONCOLOGY THERAPEUT

0.47%

H

HCMHUTCHMED CHINA-ADR

0.44%

A

ARVNARVINAS INC

0.43%

A

ANLADLAI NORTYE LTD-ADR

0.30%

Only in LABU

?

—DREYFUS GOVERNMENT CASH MANAGE

7.43%

?

—N/A

7.26%

?

—GOLDMAN FINANCIAL

6.27%

?

—GOLDMAN SACHS LIQ ES FD A

1.71%

1

1JKAPELLIS PHARMACEUTICALS INC

1.44%

T

TVTXTRAVERE THERAPEUTICS INC

1.25%

A

ARWRARROWHEAD PHARMACEUTICALS IN

1.11%

T

TWSTTWIST BIOSCIENCE CORP

1.10%

A

ALKSALKERMES PLC

1.07%

T

TGTXTG THERAPEUTICS INC

1.06%

M

MDGLMADRIGAL PHARMACEUTICALS INC

1.06%

B

BEAMBEAM THERAPEUTICS INC

1.02%

A

APGEAPOGEE THERAPEUTICS INC

0.98%

S

SRRKSCHOLAR ROCK HOLDING CORP

0.95%

P

PRAXPRAXIS PRECISION MEDICINES I

0.95%

M

MIRMMIRUM PHARMACEUTICALS INC

0.93%

U

UTHRUNITED THERAPEUTICS CORP

0.92%

C

CRSPCRISPR THERAPEUTICS AG

0.92%

K

KRYSKRYSTAL BIOTECH INC

0.91%

P

PTGXPROTAGONIST THERAPEUTICS INC

0.90%

N

NBIXNEUROCRINE BIOSCIENCES INC

0.89%

I

INCYINCYTE CORP

0.89%

C

CYTKCYTOKINETICS INC

0.89%

I

IONSIONIS PHARMACEUTICALS INC

0.88%

P

PCVXVAXCYTE INC

0.88%

Hold CANC and LABU together? See your combined true holdings, overlap, and blended fees — free, no signup.

Unwrap your portfolio →

Other comparisons you might like

LABU vs BIPIXBIOTECHNOLOGY ULTRASECTOR PROFUND

LABU vs XBIState Street(R) SPDR(R) S&P(R) Biotech ETF

LABU vs BIBProShares Ultra Nasdaq Biotechnology

LABU vs IBBQInvesco Nasdaq Biotechnology ETF

LABU vs IBBiShares Biotechnology ETF

CANC vs PRHSXT. Rowe Price Health Sciences Fund, Inc.

Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.